Grantham, Mayo, Van Otterloo & Co (GMO)’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$774M Buy
3,902,335
+281,066
+8% +$65.5M 1.98% 17
2025
Q4
$972M Buy
3,621,269
+267,415
+8% +$67.9M 2.48% 13
2025
Q3
$827M Buy
3,353,854
+705,290
+27% +$184M 2.33% 16
2025
Q2
$792M Buy
2,648,564
+208,816
+9% +$63.6M 2.38% 14
2025
Q1
$761M Buy
2,439,748
+208,461
+9% +$73.6M 2.4% 12
2024
Q4
$785M Buy
2,231,287
+46,073
+2% +$16.6M 2.55% 11
2024
Q3
$772M Buy
2,185,214
+152,487
+8% +$50.1M 2.42% 13
2024
Q2
$617M Buy
2,032,727
+155,196
+8% +$47.5M 2.08% 15
2024
Q1
$651M Buy
1,877,531
+289,614
+18% +$106M 2.36% 12
2023
Q4
$557M Buy
1,587,917
+42,113
+3% +$13.6M 2.46% 8
2023
Q3
$475M Buy
1,545,804
+21,371
+1% +$6.73M 2.24% 8
2023
Q2
$470M Buy
1,524,433
+160,507
+12% +$46.6M 2.18% 10
2023
Q1
$390M Buy
1,363,926
+162,032
+13% +$44.2M 1.98% 11
2022
Q4
$321M Sell
1,201,894
-17,859
-1% -$4.94M 1.71% 16
2022
Q3
$314M Sell
1,219,753
-87,797
-7% -$25.4M 1.81% 11
2022
Q2
$363M Sell
1,307,550
-18,581
-1% -$5.58M 1.97% 9
2022
Q1
$447M Buy
1,326,131
+18,718
+1% +$6.31M 2.16% 10
2021
Q4
$542M Sell
1,307,413
-128,388
-9% -$46.8M 2.6% 6
2021
Q3
$459M Sell
1,435,801
-288,255
-17% -$93.8M 2.27% 9
2021
Q2
$508M Buy
1,724,056
+23,474
+1% +$6.72M 2.54% 6
2021
Q1
$470M Buy
1,700,582
+8,746
+0.5% +$2.26M 2.57% 6
2020
Q4
$442M Sell
1,691,836
-12,400
-0.7% -$2.97M 2.71% 6
2020
Q3
$385M Buy
1,704,236
+30,195
+2% +$6.92M 2.74% 7
2020
Q2
$359M Buy
1,674,041
+6,865
+0.4% +$1.3M 2.67% 5
2020
Q1
$272M Buy
1,667,176
+106,688
+7% +$20.6M 2.27% 10
2019
Q4
$329M Sell
1,560,488
-163,651
-9% -$31.9M 2.19% 11
2019
Q3
$332M Buy
1,724,139
+43,459
+3% +$8.41M 2.3% 7
2019
Q2
$311M Sell
1,680,680
-122,817
-7% -$22.1M 2.19% 7
2019
Q1
$317M Sell
1,803,497
-139,600
-7% -$21.9M 2.28% 8
2018
Q4
$274M Sell
1,943,097
-99,193
-5% -$15.7M 2.19% 11
2018
Q3
$348M Sell
2,042,290
-120,233
-6% -$20M 2.36% 8
2018
Q2
$354M Sell
2,162,523
-254,405
-11% -$39.6M 2.51% 7
2018
Q1
$371M Buy
2,416,928
+41,014
+2% +$6.5M 2.27% 7
2017
Q4
$364M Sell
2,375,914
-27,452
-1% -$3.98M 2.15% 9
2017
Q3
$325M Sell
2,403,366
-393,103
-14% -$51.2M 1.9% 12
2017
Q2
$346M Buy
2,796,469
+97,949
+4% +$11.9M 1.91% 13
2017
Q1
$323M Sell
2,698,520
-105,221
-4% -$12.6M 1.82% 14
2016
Q4
$328M Sell
2,803,741
-200,961
-7% -$23.9M 1.77% 13
2016
Q3
$367M Sell
3,004,702
-147,788
-5% -$16.8M 1.73% 15
2016
Q2
$357M Buy
3,152,490
+756,041
+32% +$87.7M 1.47% 17
2016
Q1
$277M Sell
2,396,449
-26,297
-1% -$2.7M 1.03% 27
2015
Q4
$253M Sell
2,422,746
-257,093
-10% -$27.1M 0.91% 28
2015
Q3
$263M Sell
2,679,839
-565,852
-17% -$56.1M 0.91% 24
2015
Q2
$314M Sell
3,245,691
-978,900
-23% -$93.6M 1.01% 25
2015
Q1
$396M Sell
4,224,591
-319,010
-7% -$28.5M 1.18% 21
2014
Q4
$406M Buy
4,543,601
+645,830
+17% +$53.6M 1.09% 24
2014
Q3
$317M Buy
3,897,771
+32,294
+0.8% +$2.59M 0.84% 30
2014
Q2
$312M Buy
3,865,477
+180,900
+5% +$14.5M 0.85% 30
2014
Q1
$294M Buy
3,684,577
+1,201,409
+48% +$98.7M 0.77% 32
2013
Q4
$204M Buy
2,483,168
+1,535,374
+162% +$116M 0.5% 41
2013
Q3
$69.8M Buy
947,794
+234,296
+33% +$17.3M 0.18% 69
2013
Q2
$51.3M Buy
+713,498
New +$56.7M 0.13% 77

Other funds holding ACN

Grantham, Mayo, Van Otterloo & Co (GMO)'s ACN Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Accenture (ACN) stake by 7.8% in Q1 2026, buying an estimated $65.5M and bringing the position to 3,902,335 shares worth $774M. The position accounts for 1.98% of the portfolio, ranked #17.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ACN in Q2 2013 and has held it in 52 quarters since. The position peaked at $972M in Q4 2025. 2,149 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 3,902,335 shares of Accenture worth $774M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 281,066 Accenture shares in Q1 2026, an estimated $65.5M.
  • Accenture made up 1.98% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #17 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Accenture in Q2 2013 and has held it in 52 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Accenture position peaked at $972M in Q4 2025.
  • 2,149 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.